4.8 Review

Tumor Suppression by the Fbw7 Ubiquitin Ligase: Mechanisms and Opportunities

Journal

CANCER CELL
Volume 26, Issue 4, Pages 455-464

Publisher

CELL PRESS
DOI: 10.1016/j.ccell.2014.09.013

Keywords

-

Funding

  1. NIH [CA084069, CA102742]
  2. National Science Foundation [DGE-0718124, DGE-1256082]

Ask authors/readers for more resources

Tumor suppressors with widespread impact on carcinogenesis control broad spectra of oncogenic pathways. Protein degradation is an emerging mechanism by which tumor suppressors regulate a diversity of pathways and is exemplified by the SCFFbw7 ubiquitin ligase. Rapidly accumulating data indicate that SCFFbw7 regulates a network of crucial oncoproteins. Importantly, the FBXW7 gene, which encodes Fbw7, is one of the most frequently mutated genes in human cancers. These studies are yielding important new insights into tumorigenesis and may soon enable therapies targeting the Fbw7 pathway. Here, we focus on the mechanisms and consequences of Fbw7 deregulation in cancers and discuss possible therapeutic approaches.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available